Integrated Diagnostics Holdings PLC IDH launches third Al-Borg Scan branch (9246N)
04 Octubre 2021 - 5:48AM
UK Regulatory
TIDMIDHC
RNS Number : 9246N
Integrated Diagnostics Holdings PLC
04 October 2021
IDH launches third Al-Borg Scan branch in East Cairo's
centrally-located Heliopolis neighbourhood
The launch is part of a wider ramp up strategy as the Company
works to capitalise on the venture's growing popularity and the
attractive growth profile of Egypt's radiology segment
4 October 2021
(Cairo and London) - Integrated Diagnostics Holdings ("IDH,"
"the Company" or "the Group"), a leading consumer healthcare
company with operations in Egypt, Jordan, Sudan, and Nigeria,
announces the launch of Al-Borg Scan's third branch. The new branch
is located in the strategic Heliopolis neighbourhood of East Cairo
and will play an important role in further strengthening the
venture's brand equity. This is the first Al-Borg Scan branch to
launch in East Cairo, with the venture's first two branches
covering the Mohandessin and Shoubra neighbourhoods of West Cairo.
The branch, which will be equipped with the latest state-of-the-art
radiology technology available on the market, will offer a
full-suite of radiology services, including but not limited to
magnetic resonance imaging (MRI), computed tomography (CT), x-ray
and contrast studies, ultrasonography, echocardiography,
electrocardiography (ECG), electroencephalography (EEG),
electromyography (EMG) in addition to panoramic exams for jaws and
teeth and interventional radiology-based services. The new branch
will also include a special female-dedicated unit offering
mammographs and DEXA scans as well as multiple other
female-specific exams such as 3D and 4D gyne/obstetric ultrasounds.
Leveraging IDH's reputation in the industry, Al Borg Scan's new
branch has been able to secure collaborations with some of the
highest-ranking radiology specialists in the country, offering
patients consultations and diagnostic reports from the top experts
in the field. Moreover, thanks to IDH's growing digital
capabilities, patients visiting the branch will have access to
results and reports within 24 hours from the exam through the
Company's website and its dedicated WhatsApp account.
Commenting on the branch's inauguration, IDH CEO Dr. Hend El
Sherbini, said: "I am delighted to announce the launch of Al-Borg
Scan's third branch which sees us further expand our geographic
reach, bringing our high-quality radiology services to growing
number of patients. The launch comes as part of a wider ramp up
strategy which in the last three years has seen us effectively
expand our radiology venture in step with the growing demand for
high-quality radiology services in our home market of Egypt. This
has enabled us to capitalise on the important growth opportunities
offered by Egypt's fragmented radiology market while delivering on
our vision of providing patients with a one-stop-shop service
offering featuring both pathology and radiology."
Al-Borg Scan was launched back in 2018 in response to growing
demand from patients across the country who were seeking greater
access to high-quality radiology services. In its first three years
of operation, the venture has witnessed impressive financial and
operational growth in line with management's expectations. More
specifically, in the first half of 2021 Al-Borg Scan recorded a
124% year-on-year increase in revenues as tests performed and
patients served by the venture more than doubled versus the
comparable period of 2020, reaching 34 thousand and 28 thousand,
respectively. Remarkable top-line growth since inception coupled
with wide-ranging efficiency enhancement efforts have translated
into strong and improving profitability.
"Looking ahead, we expect to continue recording growing
contributions to consolidated revenue and profitability coming from
Al-Borg Scan as we continue to ramp up operations further. As part
of our continued expansion efforts, we are looking to inaugurate
two additional branches in the first half of 2022 while further
developing our diagnostics offering with the addition of innovative
services such as the new PET-CT scan we added in late 2020. In
parallel, we are also looking to complete the necessary modules to
obtain ACR (American College of Radiology) accreditation for
Al-Borg Scan's branches, a process we expect to conclude by
year-end 2021 and which would make Al-Borg Scan the only provider
in Egypt to boast the accreditation." Dr. El Sherbini
concluded.
-Ends-
About Integrated Diagnostics Holdings (IDH)
IDH is a leading consumer healthcare company in the Middle East
and Africa with operations in Egypt, Jordan, Sudan and Nigeria. The
Group's core brands include Al Borg, Al Borg Scan and Al Mokhtabar
in Egypt, as well as Biolab (Jordan), Ultralab and Al Mokhtabar
Sudan (both in Sudan) and Echo-Lab (Nigeria). A long track record
for quality and safety has earned the Company a trusted reputation,
as well as internationally recognised accreditations for its
portfolio of over 2,000 diagnostics tests. From its base of 495
branches as of 30 June 2021, IDH will continue to add laboratories
through a Hub, Spoke and Spike business model that provides a
scalable platform for efficient expansion. Beyond organic growth,
the Group's expansion plans include acquisitions in new Middle
Eastern, African, and Asian markets where its model is well-suited
to capitalise on similar healthcare and consumer trends and capture
a significant share of fragmented markets. IDH has been a
Jersey-registered entity with a Standard Listing on the Main Market
of the London Stock Exchange (ticker: IDHC) since May 2015 with a
secondary listing on the EGX since May 2021 (ticker: IDHC.CA).
Learn more at idhcorp.com .
The person responsible for arranging the release of this
announcement is Nancy Fahmy, Investor Relations Director at
IDH.
Contact
Nancy Fahmy
Investor Relations Director
T: +20 (0)2 3345 5530 | M: +20 (0)12 2255 7445 |
nancy.fahmy@idhcorp.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCUPGCCUUPGGUC
(END) Dow Jones Newswires
October 04, 2021 06:48 ET (10:48 GMT)
Integrated Diagnostics (LSE:IDHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Integrated Diagnostics (LSE:IDHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024